Latest Insider Transactions at Dia Medica Therapeutics Inc. (DMAC)
This section provides a real-time view of insider transactions for Dia Medica Therapeutics Inc. (DMAC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of DiaMedica Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of DiaMedica Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2026
|
Charles Pauling Semba |
BUY
Grant, award, or other acquisition
|
Direct |
3,355
+6.54%
|
$26,840
$8.42 P/Share
|
|
Jan 02
2026
|
Randall Michael Giuffre |
BUY
Grant, award, or other acquisition
|
Direct |
6,175
+1.53%
|
$49,400
$8.42 P/Share
|
|
Jan 02
2026
|
James T. Parsons |
BUY
Grant, award, or other acquisition
|
Direct |
10,095
+9.34%
|
$80,760
$8.42 P/Share
|
|
Nov 25
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
73,099
+0.82%
|
$584,792
$8.57 P/Share
|
|
Nov 24
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
40,253
+0.46%
|
$281,771
$7.89 P/Share
|
|
Nov 21
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
208,872
+2.34%
|
$1,462,104
$7.41 P/Share
|
|
Nov 21
2025
|
James T. Parsons |
BUY
Exercise of conversion of derivative security
|
Direct |
12,000
+12.02%
|
$24,000
$2.2 P/Share
|
|
Nov 20
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
128,426
+1.49%
|
$898,982
$7.41 P/Share
|
|
Nov 19
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
240,352
+2.79%
|
$1,682,464
$7.21 P/Share
|
|
Nov 18
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
182,882
+2.2%
|
$1,097,292
$6.75 P/Share
|
|
Nov 17
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
187,393
+2.3%
|
$1,124,358
$6.52 P/Share
|
|
Aug 27
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
50,772
+0.65%
|
$304,632
$6.0 P/Share
|
|
Aug 26
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
59,648
+0.77%
|
$357,888
$6.0 P/Share
|
|
Aug 25
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
338,265
+4.23%
|
$2,029,590
$6.0 P/Share
|
|
Aug 22
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
59,788
+0.81%
|
$298,940
$5.96 P/Share
|
|
Aug 21
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
48,172
+0.66%
|
$240,860
$5.96 P/Share
|
|
Aug 20
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
71,107
+0.98%
|
$355,535
$5.86 P/Share
|
|
Aug 15
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
8,233
+0.12%
|
$49,398
$6.0 P/Share
|
|
Aug 14
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
70,414
+0.98%
|
$352,070
$5.99 P/Share
|
|
Aug 13
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
293,601
+3.99%
|
$1,468,005
$5.91 P/Share
|
|
Jul 23
2025
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,542,857
+18.57%
|
$4,628,571
$3.5 P/Share
|
|
Jul 23
2025
|
Thomas Von Koch > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
2,857,142
+25.42%
|
$8,571,426
$3.5 P/Share
|
|
Jul 23
2025
|
Richard Jacinto Ii > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+7.46%
|
$1,200,000
$3.5 P/Share
|
|
Apr 07
2025
|
Richard D. Pilnik Director |
BUY
Exercise of conversion of derivative security
|
Direct |
24,000
+7.12%
|
$48,000
$2.11 P/Share
|
|
Feb 13
2025
|
Randall Michael Giuffre |
BUY
Exercise of conversion of derivative security
|
Direct |
17,000
+2.13%
|
$34,000
$2.88 P/Share
|
|
Jan 02
2025
|
James T. Parsons |
BUY
Grant, award, or other acquisition
|
Direct |
15,917
+17.34%
|
$79,585
$5.34 P/Share
|
|
Jan 02
2025
|
Randall Michael Giuffre |
BUY
Grant, award, or other acquisition
|
Direct |
10,861
+2.81%
|
$54,305
$5.34 P/Share
|
|
Jan 02
2025
|
Richard Kuntz Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,925
+29.08%
|
$49,625
$5.34 P/Share
|
|
Jan 02
2025
|
Richard D. Pilnik Director |
BUY
Grant, award, or other acquisition
|
Direct |
10,393
+3.47%
|
$51,965
$5.34 P/Share
|
|
Jan 02
2025
|
Charles Pauling Semba |
BUY
Grant, award, or other acquisition
|
Direct |
5,290
+10.6%
|
$26,450
$5.34 P/Share
|
|
Jun 28
2024
|
Jan Stahlberg > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,200,000
+18.69%
|
$2,400,000
$2.5 P/Share
|
|
Jun 28
2024
|
Thomas Von Koch > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,200,000
+17.84%
|
$2,400,000
$2.5 P/Share
|
|
Jan 02
2024
|
Charles Pauling Semba |
BUY
Grant, award, or other acquisition
|
Direct |
9,375
+19.25%
|
$18,750
$2.8 P/Share
|
|
Jan 02
2024
|
Richard Kuntz Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,285
+50.0%
|
$28,570
$2.8 P/Share
|
|
Jan 02
2024
|
Richard D. Pilnik Director |
BUY
Grant, award, or other acquisition
|
Direct |
30,357
+9.83%
|
$60,714
$2.8 P/Share
|
|
Jan 02
2024
|
James T. Parsons |
BUY
Grant, award, or other acquisition
|
Direct |
21,428
+26.34%
|
$42,856
$2.8 P/Share
|
|
Jan 02
2024
|
Randall Michael Giuffre |
BUY
Grant, award, or other acquisition
|
Direct |
19,196
+5.0%
|
$38,392
$2.8 P/Share
|
|
Nov 16
2023
|
David J. Wambeke Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
20,000
+3.66%
|
$40,000
$2.46 P/Share
|
|
Jun 23
2023
|
Thomas Von Koch > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
1,470,588
+25.37%
|
$4,411,764
$3.4 P/Share
|
|
Jun 23
2023
|
Randall Michael Giuffre |
SELL
Bona fide gift
|
Direct |
15,000
-4.16%
|
-
|
|
Jun 23
2023
|
Randall Michael Giuffre |
BUY
Open market or private purchase
|
Direct |
65,000
+15.28%
|
$195,000
$3.91 P/Share
|
|
Jun 23
2023
|
Dietrich John Pauls President & CEO |
BUY
Open market or private purchase
|
Direct |
12,787
+15.71%
|
$38,361
$3.91 P/Share
|
|
Jun 23
2023
|
Charles Pauling Semba |
BUY
Open market or private purchase
|
Direct |
12,787
+29.93%
|
$38,361
$3.91 P/Share
|
|
Jun 23
2023
|
Scott Kellen CFO & Secretary |
BUY
Open market or private purchase
|
Direct |
10,000
+23.65%
|
$30,000
$3.91 P/Share
|
|
Jun 23
2023
|
David J. Wambeke Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
38,364
+7.03%
|
$115,092
$3.91 P/Share
|
|
Jun 23
2023
|
Richard D. Pilnik Director |
BUY
Open market or private purchase
|
Direct |
38,363
+13.39%
|
$115,089
$3.91 P/Share
|
|
Apr 10
2023
|
David J. Wambeke Chief Business Officer |
BUY
Open market or private purchase
|
Direct |
468,750
+50.0%
|
$468,750
$1.6 P/Share
|
|
Jan 03
2023
|
Amy L. Burroughs Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,156
+18.97%
|
$17,156
$1.53 P/Share
|
|
Jan 03
2023
|
Randall Michael Giuffre |
BUY
Grant, award, or other acquisition
|
Direct |
35,130
+10.63%
|
$35,130
$1.53 P/Share
|
|
Jan 03
2023
|
Richard D. Pilnik Director |
BUY
Grant, award, or other acquisition
|
Direct |
55,555
+20.93%
|
$55,555
$1.53 P/Share
|